In this feature video, Dr Lilia Correa shared insights into her session presented at the 2023 AAD Annual Meeting, “Cutaneous Squamous Cell Carcinoma Updates.”
In this feature video, Dr Lilia Correa shared insights into her session presented at the 2023 AAD Annual Meeting, “Cutaneous Squamous Cell Carcinoma Updates.”
Christopher T. Ritchlin, MD, MPH, provided the keynote kickoff for the Interdisciplinary Autoimmune Summit virtual meeting April 26 by addressing advances in the treatment of immune-mediated inflammatory diseases.
Christopher T. Ritchlin, MD, MPH, provided the keynote kickoff for the Interdisciplinary Autoimmune Summit virtual meeting April 26 by addressing advances in the treatment of immune-mediated inflammatory diseases.
A 16-year-old, otherwise healthy, African American girl presented to the hospital 1 month after a rash started on the bilateral upper and lower extremities.
A 16-year-old, otherwise healthy, African American girl presented to the hospital 1 month after a rash started on the bilateral upper and lower extremities.
According to a recent study shedding light on the underlying immune mechanisms of nummular eczema, researchers have revealed that this common chronic inflammatory skin disease exhibits a dual immune response, with features resembling both...
According to a recent study shedding light on the underlying immune mechanisms of nummular eczema, researchers have revealed that this common chronic inflammatory skin disease exhibits a dual immune response, with features resembling both...
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...